Difficulty: Medium
Average Score: 95%
Practice
Select the most appropriate hypolipidemic drug for a patient with raised LDL-cholesterol level but normal triglyceride level
Correct answer
A
Rationale
The most appropriate hypolipidemic drug for a patient with raised LDL-cholesterol level but normal triglyceride level is option A) A HMG - CoA reductase inhibitor, commonly known as a statin. Statins work by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol synthesis. By reducing cholesterol production in the liver, statins effectively lower LDL-cholesterol levels, which is the primary goal in this scenario.
Option B) A fibric acid derivative is not the most appropriate choice in this case because these drugs are more effective in lowering triglyceride levels and increasing HDL-cholesterol, rather than specifically targeting LDL-cholesterol.
Option C) Probucol is not commonly used due to safety concerns and limited efficacy compared to other available hypolipidemic agents.
Option D) Nicotinic acid, also known as niacin, is more effective in lowering triglycerides and raising HDL-cholesterol levels than in significantly reducing LDL-cholesterol levels.
In an educational context, understanding the mechanisms of action and specific indications for each class of hypolipidemic drugs is crucial for making appropriate treatment decisions tailored to individual patient lipid profiles. Statins are considered first-line agents for lowering LDL-cholesterol and reducing cardiovascular risk, making them the preferred choice in patients with elevated LDL-cholesterol levels.
Option B) A fibric acid derivative is not the most appropriate choice in this case because these drugs are more effective in lowering triglyceride levels and increasing HDL-cholesterol, rather than specifically targeting LDL-cholesterol.
Option C) Probucol is not commonly used due to safety concerns and limited efficacy compared to other available hypolipidemic agents.
Option D) Nicotinic acid, also known as niacin, is more effective in lowering triglycerides and raising HDL-cholesterol levels than in significantly reducing LDL-cholesterol levels.
In an educational context, understanding the mechanisms of action and specific indications for each class of hypolipidemic drugs is crucial for making appropriate treatment decisions tailored to individual patient lipid profiles. Statins are considered first-line agents for lowering LDL-cholesterol and reducing cardiovascular risk, making them the preferred choice in patients with elevated LDL-cholesterol levels.